• STAT+: A CRISPR 2.0 pioneer, expecting credit on its own invention, is ruffled by a competitor

    21 days ago - By STAT

    Last week, the genome-editing scientists behind base editing , a technology dubbed CRISPR 2.0, gathered for an update from the competition. Intellia Therapeutics, a company invested in the classic form of CRISPR, was to unveil its take on base editing, a refined approach to fixing DNA that corrects single letters of the genome without breaking
    The presentation, hosted by the famed Cold Spring Harbor Laboratory, sounded familiar. Continue to STAT+ to read the full story...
    Read more ...